Not a good buy right now for an impatient buyer: price action is still bearish (heavy selloff, negative/expanding MACD) and there is no Intellectia buy signal to lean on.
If you already own it, the stock is approaching a major support zone (~$58.5–$66.3), and RSI is oversold, which argues more for HOLD than panic-selling after a -8.9% drop.
To turn into a buy, OKLO likely needs stabilization/reversal signals (e.g., reclaiming ~$66.3 and then building acceptance above ~$78.96 pivot) or a clear event catalyst tied to deployment/regulatory milestones.
Technical Analysis
Trend/price context: OKLO is in a sharp pullback (today -8.94%; pre-market -2.07%) and is trading below S1 (66.33) and near S2 (58.52), signaling a weak near-term trend.
Momentum: MACD histogram -2.707 and negatively expanding → bearish momentum is strengthening, not fading yet.
RSI: RSI(6) ~23 → technically oversold (despite the provided label saying “neutral”), which can fuel short bounces, but oversold alone is not a reliable “buy now” trigger during a downtrend.
Moving averages: “Converging” MAs suggests consolidation/transition, but with today’s breakdown the tape currently favors sellers.
Key levels: Support $66.33 then $58.52; resistance $78.96 pivot, then $91.59 and $99.40. A stronger buy setup would be a reclaim/hold above $66.33 and improving MACD.
Intellectia Proprietary Trading Signals: AI Stock Picker = no signal today; SwingMax = no recent signal → removes the strongest “buy-now” priority triggers.
Options Data
Bullish
Open Interest Put-Call Ratio
Bearish
Option Volume Put-Call Ratio
Positioning (Open Interest PCR 0.78): more call open interest than puts → market positioning leans bullish/constructive longer-term.
Flow (Volume PCR 1.13): put volume exceeds call volume today → near-term sentiment is more defensive/bearish (consistent with the selloff).
Volatility: IV30 ~111% vs historical vol ~98% with IV percentile ~50 → options are expensive but not at extremes; market expects big moves to continue.
Activity vs averages: today’s option volume is ~57% of 30-day average (not a “blow-off” capitulation read), while open interest is elevated (suggesting established positioning).
Technical Summary
Sell
9
Buy
5
Positive Catalysts
Macro/policy tailwinds: ongoing pro-nuclear momentum and clean-energy initiatives can support sector multiples.
Strategic narrative: partnerships with tech companies and involvement in government-backed initiatives support the long-duration growth story.
Analyst stance is broadly constructive with multiple Buy initiations/upgrades and high price targets, which can support dips if execution milestones hit.
The stock is ~60% below its peak per the news summary, and the technicals are oversold—conditions that sometimes precede sharp reflex rallies.
Neutral/Negative Catalysts
Options tape today is defensive (put volume > call volume), aligning with risk-off sentiment.
Financial Performance
Latest reported quarter: 2025/Q3.
Revenue: $0 (no commercial revenue yet), reinforcing that the story is primarily forward-looking.
Profitability: net income is -$29.7M (still meaningfully negative); operating profile remains loss-making.
EPS: -$0.20 (still negative). Overall, the quarter does not show a clear inflection to revenue-generating operations yet—execution milestones matter more than near-term fundamentals.
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
Recent trend: sentiment from Wall Street has been improving overall (multiple Buy initiations/upgrades with high targets), but with some caution appearing via Neutral ratings and at least one notable price-target cut.
Key changes: Goldman Sachs (2026-02-04) cut PT to $91 from $106 (Neutral). BofA upgraded to Buy (2026-01-21) with PT $127. Texas Capital initiated Buy with PT $138 (2026-01-27). Seaport/Needham/B. Riley have Buy ratings with very high targets ($129–$150 range). UBS and Citi maintained Neutral while raising PTs to $95.
Wall Street pros: strong long-term upside case tied to advanced nuclear/SMR adoption, regulatory progress, and potential ecosystem synergies.
Wall Street cons: uncertainty around first-of-a-kind capex, timing of PPAs/commercialization, and the fact the company remains pre-revenue/negative earnings—making the stock highly sensitive to sentiment shifts and delays.
Wall Street analysts forecast OKLO stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for OKLO is 125.11 USD with a low forecast of 90 USD and a high forecast of 175 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
12 Analyst Rating
Wall Street analysts forecast OKLO stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for OKLO is 125.11 USD with a low forecast of 90 USD and a high forecast of 175 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
7 Buy
5 Hold
0 Sell
Moderate Buy
Current: 62.140
Low
90
Averages
125.11
High
175
Current: 62.140
Low
90
Averages
125.11
High
175
Goldman Sachs
Neutral
downgrade
$106 -> $91
AI Analysis
2026-02-04
New
Reason
Goldman Sachs
Price Target
$106 -> $91
AI Analysis
2026-02-04
New
downgrade
Neutral
Reason
Goldman Sachs lowered the firm's price target on Oklo to $91 from $106 and keeps a Neutral rating on the shares. The February Global Reactor Tracker highlights recent developments across North America, Europe, and Asia, while also noting the strong start-of-year rally in uranium spot prices and providing mark-to-market pricing forecasts ahead of Q4 earnings, the analyst tells investors in a research note.
Texas Capital
NULL -> Buy
initiated
$138
2026-01-27
Reason
Texas Capital
Price Target
$138
2026-01-27
initiated
NULL -> Buy
Reason
Texas Capital initiated coverage of Oklo with a Buy rating and $138 price target. Oklo offers "the best vehicle to express a bullish view on advanced nuclear solutions," argues the analyst, citing the company's Aurora reactor and synergistic ecosystem of advanced nuclear technology including fuel reprocessing capabilities and radioisotope production. Oklo's projected economics "can compete heads-up with other firm generation sources" and its synergistic business model "can provide additional value creation in the future," the analyst added.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for OKLO
